1月12日 - ** 基因测试公司 Tempus AI TEM.O股价盘前上涨 10.4%，报 73.19 美元
** 报告显示 (link) 总合同价值超过11亿美元，净收入保持率约为126%，均创历史新高。
** 该公司称，2025年与70多家客户签署了数据协议，其中包括阿斯利康AZN.L、辉瑞PFE.N、默克MRK.N和其他主要制药商
** 公司表示，与生命科学公司的合作达到了 "创纪录的水平"，有望在 2026 年及以后实现持续增长
** 2025 年数据与应用收入初步估计为 3.16 亿美元，同比增长约 31%
** 称 2025 财年初步收入约为 12.7 亿美元，同比增长约 83%
** TEM 股价在过去一年中上涨了约 76%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.